Oppenheimer Reiterates Outperform on Arvinas, Lowers Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Matthew Biegler has reiterated an Outperform rating on Arvinas (NASDAQ:ARVN) but has lowered the price target from $95 to $80.
February 28, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oppenheimer has maintained an Outperform rating on Arvinas but reduced the price target from $95 to $80.
While the reiteration of an Outperform rating suggests continued confidence in Arvinas' fundamentals and growth prospects, the reduction in the price target could reflect adjustments in valuation metrics or market conditions. This mixed signal might lead to short-term uncertainty among investors, potentially causing neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100